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Background: The pig is emerging as a model species that bridges the gap between rodents and humans in
research. In particular, the miniature pig (referred to hereafter as the minipig) is increasingly being used as
non-rodent species in pharmacological and toxicological studies. However, there is as yet a lack of validated
behavioral tests for pigs, although there is evidence that the spatial holeboard task can be used to assess the
working and reference memory of pigs. In the present study, we compared the learning performance of
commercial pigs and Göttingen minipigs in a holeboard task.
Methods: Biperiden, a muscarinic M1 receptor blocker, is used to induce impairments in cognitive function in
animal research. The two groups of pigs were treated orally with increasing doses of biperiden (0.05 – 20 mg.kg-1)
after they had reached asymptotic performance in the holeboard task.
Results: Both the conventional pigs and the Göttingen minipigs learned the holeboard task, reaching nearly
errorless asymptotic working and reference memory performance within approximately 100 acquisition trials.
Biperiden treatment affected reference, but not working, memory, increasing trial duration and the latency to first
hole visit at doses ≥ 5 mg.kg-1.
Conclusion: Both pig breeds learned the holeboard task and had a comparable performance. Biperiden had only a
minor effect on holeboard performance overall, and mainly on reference memory performance. The effectiveness
needs to be evaluated further before definitive conclusions can be drawn about the ability of this potential
cognition impairer in pigs.
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Although most preclinical studies in neurosciences are
performed using rodents, in particular mice, the pig is
increasingly being used as a model species because it can
bridge the anatomical/physiological gap between rodents
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reproduction in any medium, provided the or(referred to hereafter as the minipig) is gaining popularity
as laboratory animal in pharmacological and toxicological
studies [4]; however, pigs have not been used extensively
in behavioral studies, mainly because there are few vali-
dated behavioral tests for pigs. Recent systematic reviews
have found pigs able to acquire a broad range of learning
and memory tasks [5-7], such as the holeboard task [8,9].
The holeboard is a food-rewarded maze, where bait can
be found in different places, and the animal is free to visit
these places in whatever order it chooses. Once an animal
has visited a place and consumed the food, that place is not
rebaited during a trial and thus return visits to the sameLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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only be found in a subset of potential sites, then two
memory components can be distinguished and measured
simultaneously: spatial working memory (WM) and refer-
ence memory (RM) [11]. WM holds information that is
relevant only within a specific trial, such as a list of loca-
tions that have recently been visited/explored. An animal
thus must process the temporal context associated with
an event – “what happened, and when did it happen” –
and keep in mind which locations have already been
visited, in order to efficiently deal with the spatial WM
component of a task [12]. The information is transiently
held in memory until the specific trial has been completed
and is of no value for performing the next trial. RM holds
information about the solution of the spatial holeboard
discrimination task, such as the localization of the food
and the actions necessary to get the bait [13], for example,
lifting up a ball covering each food bowl with the snout
[9]. RM thus stores the general rules of a task. It retains
relevance across many trials and is thus trial independent,
but learning task specific. Little is known about the ability
of Göttingen minipigs to learn the holeboard task. Manton
[14] tested minipigs in a holeboard at the ages of approxi-
mately 59, 88, and 93 days, on each occasion over 2 con-
secutive days with 3 training trials per day, and found the
animals to have a very poor WM and RM performance,
with RM performance hardly exceeding chance level.
Central cholinergic neurotransmission appears to be
involved in spatial learning and memory processes [15].
Of the five known muscarinic receptor subtypes, M1,
M2, M4, and M5 are found in the human brain. M1,
M2, and M4 receptors are abundant in the hippocampus
and cortex, areas that that involved in learning and
memory. Blockade of these receptors thus is expected to
induce cognitive deficits [16]. The non-selective muscarinic
receptor antagonist scopolamine is used to induce cognitive
impairments in animal models of disorders characterized
by cognitive dysfunctions [17], such as Alzheimer’s disease.
Bouger and van der Staay [18] showed that administration
of scopolamine (or the non-competitive NMDA antagonist
MK-801) in well-trained rats transiently, but consistently,
impaired WM and RM in a conefield, a variant of the
holeboard. Recently, it has been suggested that biperiden, a
muscarinic M1 receptor antagonist [16], may be better
suited to induce cognitive deficits in animal experiments
[19]. Biperiden (manufactured as Akineton by BASF/Knoll
Pharma, New Jersey, USA) is generally used as an antipar-
kinsonian agent in humans. In humans, the drug has a
poor availability of only 13% after oral administration;
its bioavailability after systemic administration is 33%
(+/- 5%). The tmax of biperiden is 0.5–1.5 h and the t½ is
21 h (+/- 3.1 h). [20] Biperiden appears to be tolerated
in high dosages before overt and lethal toxicity occurs:
an oral LD50 of 750 mg.kg
-1 has been reported for ratsand 340 mg.kg-1 for dogs [21]. Common observable side
effects and neuropsychiatric signs include dry mouth,
drowsiness, agitation, anxiety, hyperactivity, ataxia, and
loss of memory [22].
In line with the expectation that M1 receptor blockade
would impair cognition, biperiden-induced cognitive
deficits have been observed in different species, includ-
ing humans [23]. In humans, motor learning as well as
visuospatial processes were impaired after oral administra-
tion of 2 mg biperiden [23]. Silver et al. [24] observed that
biperiden (2 mg twice daily) given to schizophrenic patients
impaired performance on the Benton Visual Retention Test
and the visual subscale of the Wechsler Memory Scale.
Similarly, Liang et al. [25] showed that patients with
schizophrenia treated twice daily with 2 mg biperiden had
impaired cognitive functions, tested using the Mini
Mental State Examination (MMSE). In rats, biperiden has
been found to impair responding at 10 mg.kg-1 and to
impair short-term memory in a series of operant learning
and memory tasks [19], but it did not affect food moti-
vation or attention. In another study, biperiden (4, 8, or
16 mg.kg-1, injected intraperitoneally) delayed consolidation
in a passive avoidance task [26].
As scopolamine is a non-selective muscarinic receptor
antagonist, it is difficult to establish whether its behavioral
effects are mediated centrally (cognitive) or peripherally
(side effect). Biperiden might be a better choice because it
is more selective. Moreover, scopolamine is usually admi-
nistered intraperitoneally or intramuscularly [17], but in
pigs these routes of administration might be unduly
stressful, which could interfere with learning [27]. In con-
trast, biperiden is administered orally. Oral administration
in food is the least stressful and preferred way to adminis-
ter drugs to pigs provided that the drug-containing food
does not induce food aversion and is palatable [28]. As we
would like to know whether Göttingen minipigs are suit-
able for studying cognitive function, we tested whether 1)
conventional pigs and age-matched Göttingen minipigs
learn the holeboard task at a similar speed and to a similar
asymptotic performance level, and 2) whether orally admi-
nistered biperiden transiently impairs spatial memory in
pigs. We expected that the Göttingen minipigs would be
able to learn the holeboard task as good as conventional
pigs do and that biperiden would impair cognition in both
pig lines, as was found earlier with rats [19]. We expect
biperiden to be an interesting alternative for scopolamine
for inducing cognitive impairment.
Material and methods
Ethical approval
The experiments were reviewed and approved by the local
ethics committee (DEC, dierexperimentencommissie) and
were conducted in accordance with the recommendations
of the EU directive 86/609/EEC. All efforts were made to
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suffering.
Animals
Eight female Göttingen miniature pigs (supplier: Ellegaard
Göttingen Minipigs A/S, Dalmose, Denmark) and 8 female
piglets [Duroc X (Fin X York)] born at the pig-breeding
farm of Utrecht University were used. Healthy piglets from
different litters were selected after weaning and were
moved in a covered trolley to our experimental facility
when they were 4–6 weeks old. The minipigs were trans-
ported from Denmark to the Netherlands in a climate-
controlled minivan.
Housing
The pigs were housed together per breed in two adjacent
identical pens of 20 m2, situated in a large, naturally
ventilated and lit stable. The pens had a concrete floor,
covered with straw bedding; drinking water was provided
ad libitum. A covered piglet nest, a play ball, and chewing
sticks were provided per pen. In addition, a heating mat
(25°C) covered with straw was installed in the nest of the
Göttingen minipigs. All pigs were fed twice a day, once in
the early morning (1/3 of their daily feed ration in the
morning, about 1 hour before testing started) and once in
the late afternoon (2/3 of their daily feed ration after com-
pletion of daily holeboard training). The Göttingen minipigs
were fed on a diet according to the recommendations of
the breeder. All pigs were weighed at least once a week.
Testing room
The testing equipment was located in the room next to the
pens. The testing room consisted of a corridor, a waiting
area, and the holeboard apparatus. All pigs from one group
were walked down the corridor and entered the straw- and
toy-enriched waiting area (11.5 m2, ad libitum access to
drinking water) of the testing apparatus. Then the experi-
menter let one pig into the testing apparatus. After testing,
the pig returned to the waiting area.
Drug
Akineton tablets (containing 2 mg Biperiden; producer:
Abbott Laboratories) were crushed and mixed with con-
ventional pig food, honey (to make it more palatable),
and some water into a ball.
Apparatus
The holeboard consisted of a square arena measuring
530 by 530 cm, with a 4×4 matrix of food bowls (for a
schematic overview of the apparatus see [9]). The blue
synthetic floor was slatted and the gray synthetic walls
(height: 80 cm) had a steel bar on top (at a height of
100 cm). The arena had four entries (one on each side)
through guillotine doors that were operated from theoutside by the experimenter using pulley strings. By
walking down a small corridor (width: 40 cm) surrounding
the entire arena, the animals found the opened door and
entered the holeboard on their own initiative. The appa-
ratus (arena and corridor) was elevated above the floor.
The testing room provided adequate extra-maze cues.
To prevent the pigs from locating rewards based on
smell, all food bowls had false bottoms under which fresh
rewards (M&M milk chocolatesW) were placed daily. To
prevent the animals from locating the rewards visually, each
bowl was covered with a synthetic red ball (Jolly Ball Dog
Toy, diameter: 24 cm, weight: 400 g). The pigs could get at
the reward by lifting the ball with their snout; the ball rolled
back on the bowl as soon as the pig withdrew its head. The
apparatus was cleaned with water before the next trial, and
the entire apparatus was rinsed with water daily after use.
Habituation
When the pigs were approximately 10 weeks old, they were
gradually exposed to their handlers, the testing room, and
the apparatus, as described by Gieling et al. [9]. During the
first week of habituation, the pigs were allowed to get used
to the experimenters and the waiting area, and from the
second week they were habituated to the holeboard. The
pigs had four daily sessions of 20 minutes per pen. The ani-
mals were first habituated to the holeboard in groups of 8
pigs, then in groups of 4 pigs, and lastly in groups of 2 pigs.
During the habituation period, all food bowls contained
M&Ms. Individual pigs were habituated to the holeboard
during four trials/day on 10 successive working days until
the pig had found all rewards or 10 minutes had passed,
whichever event occurred first. The next working day,
training was started.
Acquisition
When the pigs were about 13 weeks old, formal training in
the holeboard started. Each animal was assigned its own
configuration of four rewarded holes. Four different config-
urations were used (determined using the rule outlined in
Figure 4K in [10]: a basic configuration (Figure 4E in [10])
and its three rotations (90, 180, and 270 degrees). In this
way, all sixteen holes were rewarded equally often. The en-
trance door was randomly chosen for each trial. Each pig
received 2 acquisition sessions of 2 trials each day (1 session
in the morning and 1 session in the afternoon) for the first
13 working days (i.e. 26 sessions). Then, from working day
14 to 40, each daily session consisted of 2 massed trials.
The acquisition phase consisted of 104 trials. Testing was
never performed during weekends.
Data collection
Data collection was automated. Each food bowl was
equipped with a hidden sensor. If the ball (which was fitted
with a magnet) on top of the bowl was lifted, a signal was
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Personal Computer (OS: Windows XP), using the custom
made software ‘Experiment control for University Utrecht’
(Blinq Systems, Delft, The Netherlands). A trial ended auto-
matically after an animal had found all rewards or 10 min-
utes had elapsed.
Drug treatment
After they reached asymptotic performance, all pigs were
treated with increasing doses of biperiden (0.05 mg.kg-1,
0.15, 1.5, 5, 15 and 20 mg.kg-1; the lowest dose corresponds
to the therapeutic dose in humans) administered orally
1.5 hours before holeboard testing started. As in the trai-
ning trials, testing consisted of 2 trials in close succession.
At 8:30, the first pig was given its ball of food containing
biperiden in a food bowl (to prevent spoiling), followed at
15-minute intervals by the other pigs in random order. This
was the order in which the pigs were tested. Pigs were given
the rest of their morning ration of feed 30 minutes after ad-
ministration of the two lowest doses of biperiden, to ensure
that their performance was not altered by hunger. This was
not necessary for the higher doses, because the drug-feed
mixture contained the pigs’ normal feed ration. Between
each drug-testing session, there was a wash-out period of at
least 2 days, based on the t½ of 18.4–24.3 hours of biperi-
den in humans and rodents. The pigs continued to train
during the wash-out periods. Biperiden was tested in ses-
sions 22 (0.05 mg.kg-1), 32 (0.15 mg.kg-1), 36 (1.5 mg.kg-1),
39 (5 mg.kg-1), 41 (15 mg.kg-1), and 44 (20 mg.kg-1).
Drug-induced side effects
The behavioral side effects of biperiden [29] were registered
by two researchers while the pigs were in the waiting area.
Behavioral sedation was scored when an animal lay down
1 minute or longer. Dry mouth (shown by yawning-like
behavior) and dry cough were scored if these behaviors
were observed more than twice.
Statistical analysis
WM and RM are expressed as ratios [10]. WM was defined
as the number of rewarded visits divided by the number of
visits to the baited set of holes. This ratio reflects the ability
of the animals to avoid re-visits to baited holes during a
trial. RM was defined as the number of visits to the baited
set of holes divided by the number of visits to all holes. This
ratio reflects the ability of animals to discriminate between
baited and unbaited holes.
To analyze differences in the speed of holeboard task
acquisition by the two groups of pigs, the means of blocks
of 4 trials (1 testing day) were calculated. Changes in WM,
RM, trial duration, and latency to first rewarded hole visit
in the course of training were assessed by an analysis of
variance (ANOVA) with the between subjects factor Pig
breed (conventional pigs vs. Göttingen minipigs) and thewithin subjects (repeated measures) factor Blocks of Trials
(SAS GLM procedure, SAS Institute, Cary, NC, USA). To
analyze the effect of acute challenge with biperiden, means
were calculated for both drug and drug-free sessions. Both
session means consisted of two successive trials. First we
tested whether the drug-free sessions differed from each
other (repeated measures ANOVA) to decide whether an
overall drug-free session mean could be used or whether
separate sessions should be analyzed. To assess whether
biperiden affects holeboard behavior, and whether this
effect is different for the two pig breeds, we performed a
Pig breed (Conventional pigs vs. Göttingen minipigs) by
Doses (0.05, 0.15, 1.5, 5, and 15 mg.kg-1 Biperiden) by
Sessions (Control session preceding Biperiden treatment
vs. Biperiden session) ANOVA with repeated measures on
the second and third factors. Unfortunately, one of the con-
ventional pigs did not eat the 15 mg.kg-1 dose of biperiden,
so the data for this pig were omitted from the repeated
measures analysis. Because the conventional pigs did not
eat the entire of 20 mg.kg-1 dose of biperiden, only the
doses up to 15 mg.kg-1 were considered for comparisons
between pig breeds. In addition, we analyzed the effects of
biperiden in the Göttingen minipigs by a Doses by Sessions
repeated measures ANOVA for all doses tested (i.e. includ-
ing the 20 mg.kg-1 biperiden dose). An alpha of < 0.05 was
considered significant.
Results
Acquisition of the holeboard task
Working memory
WM performance (see Figure 1A) was similar in the two
groups of pigs (F1,14 = 0.02, p = 0.8939) and improved with
training (Blocks of trials: F25,350 = 7.41, p < 0.0001) similarly
in the two groups of pigs (Pig breed X Blocks of trials
interaction: F25,350 = 1.10, p = 0.3607).
Reference memory
The Göttingen minipigs tended to have a poorer RM
(see Figure 1B) than the conventional pigs (F1,14 = 4.02,
p = 0.0646). RM performance improved across blocks of
trials (Blocks of trials: F25,350 = 104.43, p < 0.0001), and
while learning appeared to be slightly delayed in the
Göttingen minipigs (Pig breed X Blocks of trials inter-
action: F25,350 = 1.44, p = 0.0811), both groups of pigs
ultimately had a similar level of performance.
Trial duration
The two groups of pigs completed the trials at a similar
speed across all trial blocks (F1,14 = 1.31, p = 0.2708), and
trials became shorter in the course of learning (Blocks of
trials: F25,350 = 6.51, p < .0001) in both groups of pigs
(Pig breed X Blocks of trials interaction: F25,350 = 0.66,
p = 0.8910). This is shown in Figure 1C.
Figure 1 Learning of a spatial holeboard discrimination task by
conventional pigs and Göttingen minipigs. The working memory
performance (panel A) and the reference memory performance
(panel B), the trial duration (panel C) and the latency to first
rewarded hole visit (panel D) are depicted as means and standard
errors of the mean (SEM) of 26 successive blocks of 4 trials each.
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As is shown in Figure 1D, the conventional pigs gained
their first reward faster than the Göttingen minipigs
(F1,14 = 12.39, p < 0.0034), but pigs in both groups
became quicker in finding the food reward in the course
of training (Blocks of trials: F25,350 = 12.61, p < 0.0001)
(Pig breed X Blocks of trials interaction: F25,350 = 1.67, p
= 0.0252). Whereas the Göttingen minipigs needed
more time to find the first reward than the conventional
pigs during the first block of four trials (t14 = -2.19,p = 0.0462), the performance of both lines was similar
during the last block of four trials (t14 = -1.64, p = 0.1241).
Effects of biperiden
Side effects
Most pigs showed signs of a dry mouth (xerostomia)
and mild behavioral sedation (lying down for longer than
normal in the waiting area) with the higher doses of
biperiden (≥ 15 mg.kg-1) (Figure 2).
Control (drug-free) sessions
Performance during the drug-free sessions that
preceded test days did not change, with the exception of
RM (F5,70 =2.92, p = 0.0190). Contrast variables showed
that for RM only sessions 1 and 2 (F1,14 = 5.11, p = 0.0403)
and 3 and 4 (F1,14 = 9.29, p = 0.0087) differed from each
other. On the basis of these results, we decided to compare
a treatment session with its own preceding drug-free
session and not with the average of all drug free sessions
preceding a treatment session.
Working memory
The WM performance (see Figure 3A) of the two groups of
pigs, averaged over all doses up to 15 mg.kg-1 and sessions,
was not significantly different (F1,13 = 0.00, p = 0.9595), and
biperiden did not affect WM (Dose: F4,52 = 0.03,
p = 0.9979; Pig breed X Dose interaction: F4,52 = 0.89,
p = 0.4742; Session: F1,13 = 0.62, p = 0.4446.; Pig breed X
Sessions interaction: F1,13 = 0.30, p = 0.5952; Dose X Ses-
sions interaction: F4,52 = 1.55, p = 0.2012; Pig breed X Dose
X Sessions interaction: F4,52 = 0.52, p = 0.7189). However,
analysis of the data for all biperiden doses tested (0.05–
20 mg.kg-1) revealed that biperiden affected WM in
the minipigs (Doses X Sessions interaction: F5,35 = 3.25,
p = 0.0163; Doses: F5,35 = 0.46, p = 0.8020; Sessions:
F1,7 = 0.36, p = 0.5666).
Reference memory
The RM performance (see Figure 3B) of the two groups
of pigs was similar, averaged over all doses and sessions
(F1,13 = 2.00, p = 0.1807), and biperiden treatment
affected RM performance (Dose: F4,52 = 3.73, p = 0.0096)
similarly in the two groups (Pig breed X Dose interaction:
F4,52 = 0.69, p = 0.5995; Session: F1,13 = 4.66, p = 0.0501; Pig
breed X Sessions interaction: F1,13 = 0.44, p = 0.5172; Dose
X Sessions interaction: F4,52 = 2.53, p = 0.0511; Pig breed X
Dose X Sessions interaction: F4,52 = 1.17, p = 0.3339). Note
that the Sessions effect, i.e. the overall performance in the
control sessions vs. the overall performance in the drug
treatment sessions, had an associated probability close
to 0.05. This suggests that, on average, the pigs per-
formed worse in the biperiden sessions. The marginal
Dose X Sessions interaction suggests that the impair-
ment induced by biperiden was dose dependent.
Figure 2 Side effects of biperiden at different doses. Panel A: percentage of animals with signs of dry mouth (“yawning”). Panel B:
percentage of animals showing signs of behavioural sedation. Panel B: percentage of animals with dry cough. As the conventional pigs did not
eat all of the 20 mg/kg dose, the side effects of this dose are excluded for this group (Note: legend in panel C also applies to panels A and B).
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biperiden in the minipigs (Doses X Sessions interaction:
F5,35 = 2.21, p = 0.0748, Doses: F3,35 = 3.64, p = 0.0093;
Sessions: F1,7 = 4.21, p = 0.0792), with higher doses
(except 15 mg.kg-1) appearing to decrease RM perfor-
mance (see Table 1).
Trial duration
Averaged over all doses and sessions biperiden did not dif-
ferentially affect trial duration in the two groups (Doses:
F4,52 = 0.43, p = 0.7834; Pig breed X Doses interaction:
F4,52 = 1.00, p = 0.4143; Pig breed X Doses X Sessions
interaction: F4,52 = 0.88, p = 0.4842). Trial duration tended
to increase with increasing biperiden dose (Sessions:
F1,13 = 0.35, p = 0.5646; Dose X Sessions interaction:
F4,52 = 2.23, p = 0.0784; Pig breed lines X Sessions inter-
action: F1,13 = 1.17, p = 0.2997). Analysis of data for the
minipigs revealed that the higher doses of biperiden
increased trial duration more than did the lower doses
(Doses X Sessions interaction: F5,35 = 3.34, p = 0.0143;
Doses: F5,35 = 0.78, p = 0.5712; Sessions: F1,7 = 0.00,
p = 0.9525). Trial duration is shown in Figure 3C.
Latency to first rewarded hole visit
As is shown in Figure 3D, the minipigs took longer to
find the first food reward than did the conventional pigs
(F1,13 = 8.05, p = 0.0140), but biperiden did not affect the
time it took in either group (Dose: F4,52 = 1.08, p = 0.3772;
Pig breed X Dose interaction: F4,52 = 1.42, p = 0.2416).
However, across all doses tested, the pigs took longer to
find the first food reward when they were treated with
biperiden than in the preceding control session (Session:
F1,13 = 14.55, p = 0.0021), with a marginal Dose X Sessions
interaction suggesting that the higher, rather than lower,
doses of biperiden tended to increase the time it took pigs
to find the first food reward (F4,52 = 2.54; p = 0.0508). This
effect was similar for the two groups of pigs (Pig breed X
Sessions interaction: F1,13 = 0.01, p = 0.9236; Pig breed X
Dose X Sessions interaction: F4,52 = 0.04, p = 0.9968).Analysis of the data for the minipigs confirmed that this
effect of biperiden on the time taken to find the food re-
ward was not dose related (Dose X Sessions interaction:
F5,35 = 1.16, p = 0.3476).
Discussion
Both the conventional pigs and the Göttingen minipigs
learned the holeboard task. This finding corroborates and
extends earlier studies by Arts et al. [8] and Gieling et al.
[9] and confirms our hypothesis. After intensive training
(about 100 trials), the pigs reached nearly errorless asymp-
totic WM and RM performance. Moreover, all pigs had a
higher level of performance than we have ever seen in rats,
even after more that 400 training trials [18]. The holeboard
performance and motivation of minipigs were not different
from those of conventional pigs, showing that both types of
pig can be used in cognitive research. This is in marked
contrast to the conclusion drawn by Downes [30] based on
a study by Manton [14], that “the results of testing for
learning and memory in minipigs were equivocal and
ultimately disappointing”. We found that minipigs could ac-
quire the spatial holeboard discrimination task, suggesting
that Downes’ conclusions concerning testing the learning
and memory capacity of minipigs, using the holeboard task
are premature.
The cholinergic system is involved in spatial discrimin-
ation learning [15], and holeboard-type tasks are sensitive
to manipulation of cholinergic neurotransmission with so-
called cognition enhancers or cognition impairers (for a
recent review see [10]). Biperiden, an M1 receptor antag-
onist, is suggested to act as a cognition impairer [7,17,19],
but we found only marginal effects on RM and WM at
very high oral doses (5 to 20 mg.kg-1). The WM perform-
ance of the conventional pigs appeared to be unaffected
by biperiden, whereas the drug appeared to differentially
affect WM performance in the minipigs, with the lowest
dose of biperiden marginally improving WM performance
and the highest dose marginally impairing WM perform-
ance (see Table 1). On the basis of the effects of the
Figure 3 (See legend on next page.)
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Figure 3 Effects of oral administration of increasing doses of biperiden on working memory (A) and reference memory performance
(B), trial duration (C), and latency to first rewarded hole visit (D) of conventional pigs and Göttingen minipigs. The means + SEM of the
drug-free day preceding treatment and of the day of biperiden treatment are depicted. None of the conventional pigs consumed the entire
20 mg.kg-1 dose. Consequently, these data were not analyzed, and only the data of the Göttingen minipigs are shown for the highest dose of
Biperiden.
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trained rats [18], we expected that biperiden would transi-
ently affect WM and RM performance. The lowest dose of
biperiden that impaired RM in both groups of pigs was
5 mg.kg-1, which is in the dose range that was found to
affect cognition in rats [19]. Thus although we had
expected that biperiden would transiently impair spatial
memory in conventional pigs and age-matched minipigs,
once they have learned the cognitive holeboard task, we
cannot unambiguously conclude that this is the case. We
can conclude that the effects found on RM are compa-
rable for both breeds, although the highest dose could not
be tested in conventional pigs.
It may be difficult to impair memory performance once a
task has been learned to almost perfection, but previous
studies with the conefield task, a variant of the holeboard
task, have shown that the near-maximal, asymptotic WM
and RM performance of rats could be decreased with the
cognition impairers scopolamine and MK-801. In the drug-
free session following each of the scopolamine or MK-801
sessions, the WM and RM performance returned to control
level [18]. Although the rats reached an asymptotic per-
formance, they did not reach the maximum performance
possible (ceiling level). In the current study, the peak
performance of the pigs was close to the maximumTable 1 Biperiden effects per pig line and dose of Biperiden
Biperiden (mg.kg-1
body mass, p.o.)
Conventional pigs Göttingen m
Working memory
0.05 t8 = 0.36 p = 0.7318 t8 = 2.05 p
0.15 t8 = -0.24 p = 0.8157 t8 = 1.63 p
1.5 t8 = 0.39 p = 0.7055 t8 = 0.55 p
5 t8 = 0.14 p = 0.8916 t8 = -0.62 p
15 t7 = -0.46 p = 0.6585 t8 = -0.41 p
20 n.t. t8 = -2.50 p
Trial duration
0.05 t8 = -0.81 p = 0.4427 t8 = -1.31 p
0.15 t8 = 0.89 p = 0.4032 t8 = -1.45 p
1.5 t8 = -0.49 p = 0.6358 t8 = -0.78 p
5 t8 = 4.27 p = 0.0037 t8 = 0.21 p
15 t7 = 1.55 p = 0.1725 t8 = 2.05 p
20 n.t. t8 = 1.98 p
One-sample t-statistics and the associated p-values of the difference scores betwee
sessions are tabulated. Abbreviation: n.t. not tested, because none of the conventio
bold and italicized, p-values between 0.05 and 0.1 (marginal effects) are italicized.performance level possible. In order to detect cognition-
impairing effects, it might be appropriate to give biperiden
earlier, before pigs reach an asymptotic level of perform-
ance, or the task could be made more difficult (e.g. hide 5
instead of 4 rewards). This is supported by the observation
that while the performance of laboratory animals in the
conefield task can be altered by cognition impairers [18],
performance in other spatial learning and memory tasks,
such as the Morris water escape task, is unresponsive to
the effects of cognition impairers once the task has been
learned to an asymptotic level [31]. In a study involving
a well-learned operant task and rats [32], biperiden at
doses of 0.25 and 0.5 mg.kg-1 increased the number of
nonreinforced responses and decreased the number of
reinforcements obtained. Doses exceeding 0.5 mg.kg-1
already led to long pauses in responding and omissions to
respond. In pigs, doses equal to and exceeding 5 mg.kg-1
tended to increase trial duration and the time taken to find
the first food reward. The longer trial duration may have
been caused by a longer time taken to visit the first hole
and an increase of the number of erroneous hole visits be-
fore all the baits were found (RM errors).
Our findings suggest that conventional and minipigs dif-
fer in their sensitivity to the disruptive effects of biperiden
with only the conventional pigs starting to refuse theinipigs Conventional pigs Göttingen minipigs
Reference memory
= 0.0796 t8 = 1.18 p = 0.2765 t8 = 0.34 p = 0.7425
= 0.1477 t8 = 0.09 p = 0.9332 t8 = -0.66 p = 0.5277
= 0.5983 t8 = -1.43 p = 0.1966 t8 = 0.27 p = 0.7986
= 0.5577 t8 = -2.96 p = 0.0212 t8 = -4.75 p = 0.0021
= 0.6975 t7 = -2.41 p = 0.0528 t8 = -0.22 p = 0.8316
= 0.0412 n.t. t8 = -3.55 p = 0.0094
Latency to first rewarded hole visit
= 0.2325 t8 = -1.00 p = 0.3519 t8 = -1.25 p = 0.2522
= 0.1895 t8 = 0.08 p = 0.9375 t8 = 0.29 p = 0.7797
= 0.4612 t8 = -1.18 p = 0.2749 t8 = -0.74 p = 0.4831
= 0.8401 t8 = -1.63 p = 0.1476 t8 = -1.98 p = 0.0876
= 0.0792 t7 = -3.00 p = 0.0241 t8 = -1.57 p = 0.1614
= 0.0887 n.t. t8 = -5.11 p = 0.0014
n the control sessions preceding treatment and the corresponding treatment
nal pigs consumed the entire dose of 20 mg.kg-1. p-values < 0.05 are printed
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have been caused by differences in body composition.
Leanness significantly affects the volume of distribution of
a drug and hence its adverse responses. Moreover, biperi-
den is highly lipophilic, rapidly entering the brain, but
slowly entering fat tissue, from where it is slowly cleared
[33]. Although we did not measure the proportion of body
fat, we presumed that the conventional pigs were leaner
than the minipigs. If this is the case, then minipigs are not
necessarily less sensitive to the pharmacological effects of
the biperiden, but instead have different pharmacokinetics.
Although we found that biperiden did not impair retrieval
of well-consolidated information from RM, and within-trial
WM, it remains to be seen whether biperiden affects the
learning process and/or memory consolidation. This can be
assessed by administering biperiden before or immediately
after the daily training trials during acquisition of the
holeboard task. Biperiden has been found to impair consoli-
dation and retrieval in a passive avoidance task with
rats [26,34].
Our data confirm that biperiden is safe, even after
administration of very high doses. The pigs were treated
orally with up to 20 mg.kg-1: biperiden, a dose approxi-
mately 400-times higher than the therapeutic dose usually
used in humans. We observed only mild non-cognitive ad-
verse effects at the highest doses tested, such as mild signs
of dry mouth [29], a typical side effect of anticholinergic
drugs [16]. Liquid reinforcements could be used to get
around the dry-mouth problem. It remains to be deter-
mined whether the reduced RM performance observed
with the highest dose of biperiden really reflects cognitive
deficits caused by a central action of biperiden or noncog-
nitive adverse drug reactions. In the latter case, biperiden
would not fulfill the requirements of a pharmacologically
active cognition impairer in pigs [31]. A potential limitation
of the study is that none of the conventional pigs ate the
mixture containing the highest dose of biperiden and one
did not did not eat the mixture containing 15 mg.kg-1
biperiden. This reluctance to eat is unlikely to have been
due to a dry mouth, because this side effect developed
about 30 minutes after drug ingestion. Dry mouth might
have diminished the attractiveness or palatability of the
M&M rewards. However, all Göttingen minipigs ate the
food containing biperiden, even though they showed
symptoms of dry mouth. The large volume of the mixture
of crushed tablets, pig feed, and honey (the latter needed to
stimulate pigs to eat the tablet mixture) may have delayed
the absorption of biperiden, such that peak plasma levels,
which were expected approximately 1–1.5 hours after drug
administration on the basis of published pharmacokinetic
data [20], were reached later. This would have led to under-
estimation of the ability of biperiden to affect spatial mem-
ory. In the future, it might be more effective to administer
pure biperiden, so that less “filler” is needed.The present study did not provide evidence to support
the conclusion drawn by Klinkenberg and Blokland [19]
that M1 receptor antagonists can be considered an alterna-
tive to scopolamine as cognition impairer, at least if
conventional or minipigs are used as subjects. We suggest
that biperiden should be evaluated further as putative
cognition impairer in pigs, but using a different way to
administer the drug. On the basis of our findings, a coun-
terbalanced design could be used in a future study, e.g.
involving the doses 1, 3, and 10 mg.kg-1. The learning task
could be made more difficult, and RM performance should
be monitored daily, so that treatment can be started before
performance reaches an asymptotic level, to prevent a
ceiling effect. On the basis of our findings, minipigs can be
used instead of conventional pigs or can serve as a transla-
tional model for other species. The effectiveness of biperi-
den treatment in conventional and minipigs clearly needs
to be evaluated further before definitive conclusions can be
drawn about the ability of biperiden to impair cognition in
this species.
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